Categories: HealthPhilippines

Surprisingly, AstraZeneca Withdraw it’s Schedule to Philippines

WhatsAppWhatsAppFacebookFacebookTwitterTwitterPinterestPinterestRedditRedditGmailGmailShareShare

One of the options Philippines have just updates the country on it’s withdrawal schedule for vaccine. In view of this, the Food and Drug Administration has shared that AstraZeneca cancelled from conducting trials for its coronavirus vaccine candidate.

The local regulators were advised by the British-Swedish drugmaker that they already had enough evidence, which is why they will no longer go ahead with the trials. The FDA Director General Eric Domingo clearly update the changes about this. He clarify that the withdrawal of AstraZeneca to perform clinical trials for its coronavirus vaccine would have no effect on the shot’s regulatory approval.

AstraZeneca’s COVID-19 vaccine was infact on the process before the ethics review board before pulling out of performing trials. In view of this, The Philippines will be left with studies performed by Sinovac Biotech Ltd., Sichuan Clover Biopharmaceuticals, Gamaleya Research Center, and Johnson and Johnson’s vaccine arm Janssen with the departure of AstraZeneca from the conduct of clinical trials

But there’s something interesting since the support of some 30 private companies that pitched in to donate the shots to the government, the Philippines secured 2.6 million doses of the still-unapproved AstraZeneca vaccine.

One of them is Carlito Galvez, the country’s vaccine czar, previously expressed trust in the drugmaker’s development of the jab, citing its reputation for producing quality drugs and vaccines that are used worldwide.

However, AstraZeneca and its affiliate, the University of Oxford, have updated that they are pursuing regulatory approval for their vaccine in the United Kingdom after showing an overall efficacy rate of 70%.

When an initial half-dose then a full dose was given, the rate jumped to 90 percent, comparable to that in rival vaccines by Pfizer/BioNTech and Moderna in growth. Morever, the US scientists, however, point out that the higher efficacy rate came in a smaller trial consisting of individuals aged 55 and that makes them conduct studies even more.

WhatsAppWhatsAppFacebookFacebookTwitterTwitterPinterestPinterestRedditRedditGmailGmailShareShare
AddThis Website Tools
Jasmine C.

Mabuhay! An upcoming Newswriter for the Asian Affairs from the Pearl of the Orient - Philippines. Avid follower of celebrity gossips, fashion news. I got into writing so that my fellow Kababayan will be constantly updated with the latest news.

Recent Posts

Seraphic Lee Young Ae To Dive into the World of Crime & Thriller in ‘Eun Soo Good Day’

The south Korean actress Lee Young Ae has shown her best majorly in the genre of period historical and emotional…

July 26, 2025

NewJeans HYBE Legal Battle: BTS Mentioned in Court as Contract Dispute Continues

The current HYBE NewJeans court case has taken a twist as the attorneys introduced the BTS group into the court…

July 26, 2025

JTBC to Stream a Special Biographical Documentary About “Actress Kim Hye-ja”

Some are born to become a legend and to leave back a legacy after their incomparable great achievement in whatever…

July 26, 2025

Asia Cup 2025 Update: Chairman of ACC Announced the Fixed Schedule

ACC (Asian Cricket Council) Chairman Mohsin Naqvi has announced officially regarding the schedule of the Asia Cup 2025. So, it…

July 26, 2025

K League 1 Championship: Standings & Fixtures of August 2025

The 2025 K League 1 has arrived half way to the tournament from its February schedule. In the mid point…

July 26, 2025

Trump Dismisses France’s Palestine Recognition Plan as Meaningless

US President Donald Trump has sharply condemned the move by his French counterpart, Emmanuel Macron, to recognize Palestine to be…

July 26, 2025